Because MYC is frequently (~70%) gained or amplified across gastric cancers5,8, we used a transposon vector containing human MYC cDNA as the universal oncogene and adapted sgRNAs to target different tumor-suppressor genes in accordance with their mutation in distinct subtypes of gastric cancer (Fig. 1b). This evidence concerns the gene MYC and gastric cancer.